Tianshui Zhongxing Bio-technology Co

Tianshui Zhongxing Bio-technology Co Forward P/E

The Forward P/E Ratio of Tianshui Zhongxing Bio-technology Co (002772.SZ) as of Oct 22, 2026 is 19.97. In the previous year, Forward P/E Ratio was 52.24 — a change of -61.78% (lower).

Forward P/E

19.97

YoY

-61.78%

Last updated:

Forward P/E Ratio of Tianshui Zhongxing Bio-technology Co is 2025 19.97 . Forward P/E Ratio of Tianshui Zhongxing Bio-technology Co was 2024 52.24 . It decreases by -61.78% lower compared to the previous year.

The Tianshui Zhongxing Bio-technology Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
59.75 CNY
Jan 1, 2019
97.77 CNY
Jan 1, 2020
35.39 CNY
Jan 1, 2021
121.67 CNY
Jan 1, 2022
42.24 CNY
Jan 1, 2023
41.91 CNY
Jan 1, 2024
52.24 CNY
Jan 1, 2025
19.97 CNY
The Tianshui Zhongxing Bio-technology Co Forward P/E history
YEARForward P/EYoY
19.97-61.78%
52.24+24.64%
41.91-0.77%
42.24-65.29%
121.67+243.76%
35.39-63.80%
97.77+63.64%
59.75+27.10%
47.01+11.41%
42.19-27.84%
58.47-20.55%
73.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tianshui Zhongxing Bio-technology Co Stock analysis

What does Tianshui Zhongxing Bio-technology Co do? Tianshui Zhongxing Bio-Technology Co., Ltd. generates revenue through the research, development, and manufacturing of edible and medical mushrooms. The company sells enoki mushroom, king oyster mushroom, and beech mushroom as its primary edible mushroom products. Through its subsidiaries, it also produces and sells medicinal mushroom, auxiliary materials, and agricultural by-products. The firm focuses on microbial technology, biological engineering, and new agricultural technologies for application and promotion. Its customer segments include consumers seeking edible and medicinal mushroom products, as well as businesses requiring agricultural technology solutions. The company's product portfolio includes edible mushrooms like enoki, king oyster, and beech varieties, alongside medicinal mushrooms and auxiliary materials. Subsidiaries handle production and distribution of these items, leveraging microbial and biological engineering technologies. The business targets both retail consumers and B2B clients in the agricultural and health sectors. Revenue streams are derived from direct sales of mushroom products and technology applications. Tianshui Zhongxing's operations are centered around edible and medical mushroom production, with subsidiaries expanding into agricultural by-products and technology services. The firm's revenue comes from selling enoki, king oyster, and beech mushrooms, medicinal mushrooms, and auxiliary materials. It serves markets requiring mushroom-based health products and agricultural technology innovations, with no mention of external partnerships or additional revenue sources. Tianshui Zhongxing Bio-technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tianshui Zhongxing Bio-technology Co stock

Forward P/E Ratio of Tianshui Zhongxing Bio-technology Co is 19.97 in 2025.

Forward P/E Ratio of Tianshui Zhongxing Bio-technology Co changed from 52.24 to 19.97, representing a -61.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Tianshui Zhongxing Bio-technology Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Tianshui Zhongxing Bio-technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Tianshui Zhongxing Bio-technology Co

All Key Metrics — Tianshui Zhongxing Bio-technology Co